Results 151 to 160 of about 25,784 (209)

Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer. [PDF]

open access: yesJ Immunother Cancer
Le DT   +19 more
europepmc   +1 more source

Modeling Human Protein Physical Interactions Involved in HIV Attachment In Silico. [PDF]

open access: yesInt J Mol Sci
Davydenko VS   +4 more
europepmc   +1 more source

Transport of CCL2 across an induced pluripotent stem cell-derived in vitro model of the human blood-brain barrier is heparan sulfate-dependent. [PDF]

open access: yesPLoS One
Williams LM   +7 more
europepmc   +1 more source

Leveraging Targeted Protein Degradation for G Protein-Coupled Receptors: The Development of CCR2 Molecular Degraders. [PDF]

open access: yesJ Med Chem
Essa K   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy